trending Market Intelligence /marketintelligence/en/news-insights/trending/PP4MuHQCyzH9W5JkTgOnVA2 content esgSubNav
In This List

Moody's says Shire's evaluation of neuroscience business is credit negative

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Moody's says Shire's evaluation of neuroscience business is credit negative

Moody's believes Shire plc's announcement that it is evaluating strategic options for its neurosciences franchise could lead to changes having negative credit implications.

The rating agency believes a separation of the unit would reduce Shire's scale, diversity and earnings. There is no impact on the company's Baa3 rating or the stable rating outlook.